A recent outbreak of so-called “werewolf syndrome” among babies in Spain prompted an investigation by health officials who eventually discovered that a drug company was mislabeling its products. A total of 17 cases of unexpected hair growth in young children — a condition known as hypertrichosis — initially left doctors puzzled, but a check of a nearby pharmaceutical company’s operations revealed the cause.
As Guardian reports, drug supplier FarmaQuimica Sur was found to be accidentally mislabeling the medication minoxidil, which is the active ingredient in hair regrowth drugs like Rogaine. The drug was distributed to pharmacies as omeprazole, a drug to treat gastric discomfort.
BGR Top Deals:
- Whoa… Amazon’s $25 Alexa smart plug is down to $5, and you’re nuts if you don’t get one
- Hurry and you can pick up a Bose sound bar for only $140
Trending Right Now:
- ‘Avengers: Endgame’ has a huge mistake that almost everybody missed
- This is your last chance to get Disney+ for under $4 a month – here’s how
- Netflix exec quietly confirms release timing for the epic show that could be the next ‘Game of Thrones’
Pharma company mix-up results in very hairy babies originally appeared on BGR.com on Fri, 30 Aug 2019 at 11:34:18 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report